EDGAR Filing Documents for 0001720725-17-000001

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001720725-17-000001

Filing Date

2017-10-25

Accepted

2017-10-25 14:39:23

Documents

Effectiveness Date

2017-10-25

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	8427
	Complete submission text file	0001720725-17-000001.txt		9500

Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104

Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 949.729.4500

Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)